← FDA Drug Approvals (Drugs@FDA)

DAPTOMYCIN IN 0.9% SODIUM CHLORIDE

NDA · New Drug Application · Sponsor: BAXTER HLTHCARE CORP · Approved 2022-01-25

Drug application

FDA Application #

NDA213645

Application type

New Drug Application

Brand name

DAPTOMYCIN IN 0.9% SODIUM CHLORIDE

Generic name

DAPTOMYCIN IN SODIUM CHLORIDE

Active ingredients

DAPTOMYCIN

Dosage form

SOLUTION

Route

INTRAVENOUS

Marketing status

Prescription

Sponsor

BAXTER HLTHCARE CORP

Manufacturer

Baxter Healthcare Corporation

First approval

2022-01-25

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown